Ambu A/S
Ambu A/S is a Danish medical device company focused on single-use and reusable solutions for airway management, endoscopy, and patient monitoring. The company sells into hospitals and other healthcare providers across international markets through a global commercial and distribution network.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueSingle-use and reusable endoscopy platforms used for visualization and minimally invasive procedures.
Products used to secure and manage patient airways during anesthesia, emergency care, and critical care.
Devices and consumables used in airway support, ventilation, and resuscitation workflows.
Monitoring-related consumables and accessories used alongside hospital equipment.
Customers
Ambu sells primarily to hospitals, hospital purchasing groups, and clinicians that need procedure-ready medical devices for airway management and endoscopy. Its products are used in operating rooms, emergency care, intensive care, and endoscopy suites, where reliability, infection control, and workflow efficiency matter. Public healthcare systems and larger integrated health networks are important buyers because they standardize device selection and procurement.
Buy airway, anesthesia, and endoscopy products for routine and acute care use across multiple departments.
Purchase single-use and reusable endoscopy tools for diagnostic and therapeutic procedures.
Use airway management and resuscitation products where procedural reliability is essential.
Buy through centralized tenders and framework agreements, often prioritizing standardization and supply security.
Strategy
Ambu’s strategy centers on expanding adoption of single-use endoscopy and strengthening its position in airway and anesthesia products. The company also emphasizes product innovation, clinical evidence, and broad hospital access, which are important in a market where switching decisions depend on procedure performance, infection control, and purchasing contracts. Maintaining a global supply chain and commercial presence supports scale across healthcare systems and tender-based channels.
This is a core growth engine and a differentiator versus reusable workflows.
Airway products provide a stable base of recurring hospital demand and customer relationships.
Broader hospital coverage improves tender participation and installed-base conversion.
Geography
Ambu is headquartered in Denmark and serves international healthcare markets through a broad commercial footprint. Its business is geographically diversified, with demand tied to hospital spending, reimbursement conditions, and procurement practices in developed healthcare systems. Because the company sells medical devices globally, currency movements and regional healthcare purchasing cycles can affect operations and reported results.
Risks
Ambu depends on hospital purchasing cycles, tender outcomes, and adoption of new device formats, so demand can vary with healthcare budgets and product switching behavior. The business also faces competition from established medical device makers and from reusable endoscopy solutions, while global manufacturing and sourcing expose it to supply-chain, tariff, and currency risks. Regulatory requirements, product performance expectations, and liability exposure are material because the company sells patient-facing medical devices.
- Hospital tender and procurement volatilityImpact: HighLikelihood: High
A meaningful share of sales depends on healthcare purchasing cycles and contract wins.
Exposure: Global hospital markets
- Competitive pressure in endoscopy and airway devicesImpact: HighLikelihood: High
Customers can compare clinical performance, price, and total cost versus alternative platforms.
Exposure: Endoscopy and airway product lines
- Regulatory and product liability exposureImpact: HighLikelihood: Medium
Medical devices are subject to approvals, post-market surveillance, and adverse-event risk.
Exposure: Patient-facing medical devices
- Tariffs and foreign exchangeImpact: MediumLikelihood: High
Global sourcing and international sales create exposure to trade costs and currency swings.
Exposure: Cross-border manufacturing and sales
Accounting
Judgemental itemsDevice sales are typically recognized when control transfers, which affects period-to-period comparability.
Impact: Channel mix and shipping terms can shift reported revenue timing.
Medical device product lifecycles and regulatory updates can create inventory write-down risk.
Impact: Can affect gross margin and working capital.
Patient-facing devices can generate return, repair, or liability claims that require estimates.
Impact: Can materially affect operating expenses and accruals.
International operations create earnings and balance-sheet exposure to exchange-rate movements.
Impact: Affects reported revenue, costs, and equity translation reserves.
Similar listed companies
Publicly listed companies with a comparable business focus.
Last updated: 24/10/2026